Amneal Pharmaceuticals, LLC: Drug Recall
Recall #D-0629-2024 · 08/01/2024
Class III: Low Risk
Recall Details
- Recall Number
- D-0629-2024
- Classification
- Class III
- Product Type
- Drug
- Recalling Firm
- Amneal Pharmaceuticals, LLC
- Status
- Completed
- Date Initiated
- 08/01/2024
- Location
- Bridgewater, NJ, United States
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 12,624 bottles
Reason for Recall
Presence of Foreign Tablets: Potential presence of Fludrocortisone Acetate Tablet USP 0.1 mg within the Methotrexate 2.5 mg 100-count Bottle.
Product Description
Methotrexate Tablets, USP, 2.5mg, 100-count Bottle, RX Only, Distributed By: Amneal Pharmaceuticals LLC, Bridgewater, NJ 08807, NDC# 69238-1423-1
Distribution Pattern
Nationwide in the USA
Other Recalls by Amneal Pharmaceuticals, LLC
- Class II: Risk 08/18/2025
- Class II: Risk 08/18/2025
- Class II: Risk 08/18/2025
- Class II: Risk 08/18/2025
- Class II: Risk 08/18/2025
Data from FDA openFDA enforcement reports. This site is not affiliated with or endorsed by the FDA. Recall information may be updated by the FDA at any time.